FI102177B1 - Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet - Google Patents
Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteetInfo
- Publication number
- FI102177B1 FI102177B1 FI913943A FI913943A FI102177B1 FI 102177 B1 FI102177 B1 FI 102177B1 FI 913943 A FI913943 A FI 913943A FI 913943 A FI913943 A FI 913943A FI 102177 B1 FI102177 B1 FI 102177B1
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- chromane
- intermediates
- therapeutically active
- novel therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Threshing Machine Elements (AREA)
- Liquid Crystal Substances (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Medicinal Preparation (AREA)
- Harvester Elements (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8904361 | 1989-12-22 | ||
| SE8904361A SE8904361D0 (sv) | 1989-12-22 | 1989-12-22 | New chroman and thiochroman derivatives |
| SE9000863 | 1990-03-12 | ||
| PCT/SE1990/000863 WO1991009853A1 (en) | 1989-12-22 | 1990-12-19 | New chroman and thiochroman derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI913943A0 FI913943A0 (fi) | 1991-08-21 |
| FI102177B FI102177B (fi) | 1998-10-30 |
| FI102177B1 true FI102177B1 (fi) | 1998-10-30 |
Family
ID=20377869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI913943A FI102177B1 (fi) | 1989-12-22 | 1991-08-21 | Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet |
Country Status (42)
| Country | Link |
|---|---|
| EP (1) | EP0460169B1 (fi) |
| JP (1) | JP2879972B2 (fi) |
| KR (1) | KR0178991B1 (fi) |
| CN (1) | CN1037438C (fi) |
| AT (1) | ATE138918T1 (fi) |
| AU (1) | AU641204B2 (fi) |
| CA (1) | CA2047237C (fi) |
| CY (1) | CY1991A (fi) |
| CZ (1) | CZ283630B6 (fi) |
| DE (1) | DE69027311T2 (fi) |
| DK (1) | DK0460169T3 (fi) |
| DZ (1) | DZ1469A1 (fi) |
| EG (1) | EG19749A (fi) |
| ES (1) | ES2087993T3 (fi) |
| FI (1) | FI102177B1 (fi) |
| GR (1) | GR3020497T3 (fi) |
| HK (1) | HK55897A (fi) |
| HR (1) | HRP920851B1 (fi) |
| HU (1) | HU211860A9 (fi) |
| ID (1) | ID945B (fi) |
| IE (1) | IE80753B1 (fi) |
| IL (1) | IL96712A (fi) |
| IS (1) | IS1665B (fi) |
| LT (1) | LT3967B (fi) |
| LV (2) | LV10449B (fi) |
| MX (1) | MX23889A (fi) |
| NO (1) | NO180336C (fi) |
| NZ (1) | NZ236407A (fi) |
| PH (1) | PH30797A (fi) |
| PL (3) | PL164592B1 (fi) |
| PT (1) | PT96304B (fi) |
| RU (1) | RU2092483C1 (fi) |
| SA (1) | SA90110186B1 (fi) |
| SE (1) | SE8904361D0 (fi) |
| SG (1) | SG48043A1 (fi) |
| SI (1) | SI9012429B (fi) |
| SK (1) | SK657890A3 (fi) |
| TW (1) | TW221056B (fi) |
| UA (1) | UA34416C2 (fi) |
| WO (1) | WO1991009853A1 (fi) |
| YU (2) | YU47936B (fi) |
| ZA (1) | ZA909708B (fi) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| ATE149480T1 (de) * | 1990-08-15 | 1997-03-15 | Lilly Co Eli | Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane |
| NZ241495A (en) * | 1991-02-08 | 1994-10-26 | Lilly Co Eli | 2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof |
| HRP920935A2 (en) * | 1991-10-08 | 1995-08-31 | Astra Ab | New therapeutically active compound |
| SE9103745D0 (sv) * | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | Aryl-triflates and related compounds |
| FR2691149B1 (fr) * | 1992-05-18 | 1994-07-08 | Adir | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5434174A (en) * | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
| SE9301732D0 (sv) * | 1993-05-18 | 1993-05-18 | Haakan Wilhelm Wikstroem | New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins |
| SE9703378D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| SE9703377D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| AU2002217742B2 (en) | 2001-01-16 | 2008-02-21 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| EP1353915A2 (en) * | 2001-01-16 | 2003-10-22 | AstraZeneca AB | Therapeutic chroman compounds |
| BR0206513A (pt) | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos |
| US7504395B2 (en) | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
| SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
| US20080221193A1 (en) * | 2006-12-22 | 2008-09-11 | Wyeth | 3-amino chromane derivatives |
| SA08290245B1 (ar) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
| CN101712672B (zh) * | 2008-10-06 | 2013-02-06 | 中国中医科学院中药研究所 | 一种治疗心脑血管系统疾病新化合物及其制备方法、用途 |
| DE102010041948A1 (de) | 2010-10-04 | 2012-04-05 | Mahle International Gmbh | Filtereinrichtung |
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22522A (en) * | 1985-09-03 | 1988-10-17 | Ciba Geigy Ag | 3-amino-dihydro-1-benzopyrans and benzothiopyrans, their pharmaceutical compositions and method of using said compounds |
| US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
-
1989
- 1989-12-22 SE SE8904361A patent/SE8904361D0/xx unknown
-
1990
- 1990-12-03 ZA ZA909708A patent/ZA909708B/xx unknown
- 1990-12-10 NZ NZ236407A patent/NZ236407A/xx unknown
- 1990-12-11 PH PH41705A patent/PH30797A/en unknown
- 1990-12-12 DZ DZ900224A patent/DZ1469A1/fr active
- 1990-12-17 IE IE453590A patent/IE80753B1/en not_active IP Right Cessation
- 1990-12-18 IL IL9671290A patent/IL96712A/en not_active IP Right Cessation
- 1990-12-19 RU SU905001901A patent/RU2092483C1/ru not_active IP Right Cessation
- 1990-12-19 AT AT91901496T patent/ATE138918T1/de not_active IP Right Cessation
- 1990-12-19 KR KR1019910700957A patent/KR0178991B1/ko not_active IP Right Cessation
- 1990-12-19 CA CA002047237A patent/CA2047237C/en not_active Expired - Fee Related
- 1990-12-19 EP EP91901496A patent/EP0460169B1/en not_active Expired - Lifetime
- 1990-12-19 ES ES91901496T patent/ES2087993T3/es not_active Expired - Lifetime
- 1990-12-19 WO PCT/SE1990/000863 patent/WO1991009853A1/en active IP Right Grant
- 1990-12-19 SG SG1996006565A patent/SG48043A1/en unknown
- 1990-12-19 DK DK91901496.9T patent/DK0460169T3/da active
- 1990-12-19 DE DE69027311T patent/DE69027311T2/de not_active Expired - Fee Related
- 1990-12-19 JP JP3501912A patent/JP2879972B2/ja not_active Expired - Fee Related
- 1990-12-19 AU AU69770/91A patent/AU641204B2/en not_active Ceased
- 1990-12-19 UA UA5001901A patent/UA34416C2/uk unknown
- 1990-12-19 IS IS3662A patent/IS1665B/is unknown
- 1990-12-20 PT PT96304A patent/PT96304B/pt not_active IP Right Cessation
- 1990-12-20 EG EG75290A patent/EG19749A/xx active
- 1990-12-21 MX MX2388990A patent/MX23889A/es unknown
- 1990-12-21 CZ CS906578A patent/CZ283630B6/cs not_active IP Right Cessation
- 1990-12-21 SK SK6578-90A patent/SK657890A3/sk unknown
- 1990-12-21 CN CN90106068A patent/CN1037438C/zh not_active Expired - Fee Related
- 1990-12-21 PL PL90288405A patent/PL164592B1/pl not_active IP Right Cessation
- 1990-12-21 PL PL90293066A patent/PL164609B1/pl not_active IP Right Cessation
- 1990-12-21 YU YU242990A patent/YU47936B/sh unknown
- 1990-12-21 PL PL90293065A patent/PL164608B1/pl not_active IP Right Cessation
- 1990-12-21 SI SI9012429A patent/SI9012429B/sl not_active IP Right Cessation
- 1990-12-21 TW TW079110767A patent/TW221056B/zh active
- 1990-12-22 SA SA90110186A patent/SA90110186B1/ar unknown
-
1991
- 1991-04-22 YU YU72191A patent/YU47923B/sh unknown
- 1991-08-21 FI FI913943A patent/FI102177B1/fi not_active IP Right Cessation
- 1991-08-21 NO NO913273A patent/NO180336C/no unknown
-
1992
- 1992-01-30 ID IDP185892A patent/ID945B/id unknown
- 1992-10-02 HR HRP-2429/90A patent/HRP920851B1/xx not_active IP Right Cessation
-
1993
- 1993-06-30 LV LVP-93-819A patent/LV10449B/en unknown
- 1993-12-30 LT LTIP1730A patent/LT3967B/lt not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00717P patent/HU211860A9/hu unknown
-
1996
- 1996-07-10 GR GR960401865T patent/GR3020497T3/el unknown
-
1997
- 1997-05-01 HK HK55897A patent/HK55897A/xx not_active IP Right Cessation
- 1997-06-05 LV LVP-97-111A patent/LV11894B/xx unknown
- 1997-09-05 CY CY199197A patent/CY1991A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI102177B1 (fi) | Menetelmä uusien terapeuttisesti aktiivisten kromaani- ja tiokromaanijohdannaisten valmistamiseksi ja välituotteet | |
| FI103506B1 (fi) | Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote | |
| HUT64314A (en) | Process for production isoxazole-4-carboxylic acid amides and hydroxi-alkylidene-cyanic-acetic acid amides and pharmaceutical preparations having these compounds | |
| NO890259D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| IL94278A0 (en) | 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them | |
| FR2581382B1 (fr) | Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes | |
| FI890257A (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi | |
| NO872671L (no) | 4-benzyloksy-3-pyrrolin-2-on-1-yl-acetamid, fremstilling og anvendelse derav. | |
| DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
| NO178622C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive kynurensyrederivater, samt mellomprodukter egnet for fremstilling derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |